Reported Earlier, Select Medical Prices Subsidiary Concentra Group Initial Public Offering Of 22.5M Common Shares At $23.50/Share
Reported Earlier, Select Medical Prices Subsidiary Concentra Group Initial Public Offering Of 22.5M Common Shares At $23.50/Share
In addition, Concentra has granted the underwriters a 30-day option to purchase up to an additional 3,375,000 shares of its common stock to cover over-allotments, if any. Concentra's common stock has been approved for listing on the New York Stock Exchange under the symbol "CON" and is expected to begin trading on July 25, 2024. The IPO is expected to close on July 26, 2024, subject to the satisfaction or waiver of customary closing conditions.
此外，Concentra已授予承銷商一個30天的購買期權，以購買其普通股多出的337.5萬股，以應對超額配售。Concentra的普通股已獲得紐約證券交易所的批准，交易標的爲"CON"，預計將於2024年7月25日開始交易。首次公開發行預計在2024年7月26日結束，需滿足或豁免慣常的收盤條件。
After the completion of the IPO, Select Medical will own 104,093,503 shares of Concentra's common stock, representing 82.23% of the total outstanding shares of Concentra's common stock (or 80.09% if the underwriters exercise in full their over-allotment option).
IPO完成後，Select Medical將擁有Concentra普通股的104,093,503股，佔Concentra普通股總流通股的82.23％（如果承銷商全部行使超額配售選擇權，則爲80.09％）。